88 SAMHSA-listed treatment centers in Alaska. Free, confidential help available 24/7.
Browse 88 verified drug and alcohol treatment facilities in Alaska. Each listing is sourced from federal databases and verified for accuracy. Use the information below to compare programs, verify insurance acceptance, and find the right facility for your needs.
Need help choosing? Call for free, confidential guidance from a treatment specialist.
CDC WONDER data places Alaska at 32.6 overdose deaths per 100k annually — at the national 32.6 figure. The state's treatment infrastructure spans every level of care recognized by ASAM, from acute medical detox through long-term outpatient maintenance.
Listings are sourced from the federal SAMHSA treatment locator and updated quarterly against state licensing-board records. No pay-for-placement.
Discharge is mile-marker zero of recovery, not the finish line. Alaska residents who engage with structured aftercare for 12+ months show materially better long-term sobriety than those who stop attending after discharge.
Maintenance outpatient therapy following IOP/PHP discharge: weekly individual sessions, monthly medication review, monthly group if needed. Often Medicaid-covered.
A drug-free environment with house rules, peer accountability, and employment expectations. Sober living can be 30 days to 12+ months. Check NARR certification.
The mutual-support landscape in Alaska includes 12-step (AA/NA), cognitive (SMART Recovery), Buddhist (Refuge), and secular (LifeRing) options. Online meetings extend access.
Buprenorphine and methadone are first-line maintenance medications for opioid-use disorder. Vivitrol (long-acting naltrexone) is an option for those who prefer non-opioid maintenance.
Certified Peer Recovery Specialists in Alaska — employment, housing, court navigation. Free via Medicaid.
Free naloxone kits at most Alaska pharmacies under standing orders. Family training is mandatory — kits in a drawer no one knows how to use don't prevent overdoses.
The first 90 days post-discharge are highest-risk. Daily community contact, scheduled therapy/coaching, MAT continuity, written relapse-response plan.
A common reason people leave treatment early in Alaska is mismatched expectations. The remedy is information: knowing the daily structure, the therapy modalities, and the social ecosystem before you arrive prevents the abrupt-exit pattern.
The standard frontline therapy for most substance-use disorders. CBT outperforms placebo and matches medication-only treatment for many alcohol and stimulant disorders.
A directive but non-confrontational style. MI works particularly well when the patient is uncertain about whether to engage in treatment.
Buprenorphine, methadone, or naltrexone for opioids; naltrexone, acamprosate, or disulfiram for alcohol. Combined with counseling.
A skills-acquisition therapy. Patients learn distress-tolerance and emotion-regulation techniques explicitly, in group format.
For trauma-affected patients, trauma-focused therapy is part of effective addiction treatment, not separate from it. EMDR, CPT, PE, and Seeking Safety are the most-studied protocols.
Twelve-step facilitation as a clinical approach is evidence-based; AA/NA participation itself is one of multiple aftercare options.
Under the federal Mental Health Parity and Addiction Equity Act, most insurance plans in Alaska must cover substance-use treatment at parity with physical-health benefits.
Aetna · Anthem · Blue Cross Blue Shield · Cigna · Humana · Kaiser Permanente · UnitedHealthcare · Medicare · Alaska Medicaid · Tricare (military) · VA Community Care
In Alaska, Medicaid is administered as Alaska Medicaid. State-licensed facilities are typically required to accept it for substance-use treatment. Verify eligibility at medicaid.gov.
Addiction is a family disease. Alaska treatment centers increasingly include family programming because it materially improves treatment retention and post-discharge relapse rates.
Most Alaska addiction treatment programs follow a similar five-step admission process. From first call to first day in treatment, expect 1–7 days depending on facility availability and insurance verification turnaround. Same-day admissions are possible for acute cases, especially at facilities providing medical detox in major Alaska metro areas.
Roughly 11–14% of Alaska residents are uninsured. The good news: every state, including Alaska, has multiple pathways to substance-use treatment for people without insurance. The hard part is navigating which to use; the options below cover most situations.
| Level | Duration | OOP (insured) | Best fit |
|---|---|---|---|
| Medical detox | 3–7 days | $0–$3,000 | Severe alcohol/opioid withdrawal |
| Residential / Inpatient | 28–90 days | $0–$10,000 | Moderate-to-severe addiction, 24/7 structure needed |
| Partial Hospitalization (PHP) | 2–6 weeks | $0–$5,000 | 20+ hrs/wk structured care |
| Intensive Outpatient (IOP) | 8–12 weeks | $0–$2,500 | 9–19 hrs/wk, fits work/school |
| Standard Outpatient | 3–12+ months | $0–$1,500 | Aftercare or mild dependence |
Targeted programming is now table stakes at mid-size Alaska facilities — generic mixed-group programming is no longer the default for veterans, adolescents, or dual-diagnosis patients.
Trauma-informed care, pregnancy-aware medical management, parenting groups.
Emotion-regulation focus, anger management, fatherhood support, identity processing.
School integration, family therapy required, lower-intensity longer-duration models.
Combat-trauma-aware programming, VA Community Care eligibility, military culture competence.
Identity-affirming therapy, anti-discrimination policies, family-of-choice integration.
Psychiatry on staff, integrated treatment of depression/anxiety/PTSD/bipolar alongside substance use.
Nursing/physician recovery monitoring, confidential reporting, return-to-practice protocols.
Late-onset alcohol-use disorder, polypharmacy concerns, age-appropriate group composition.
All statistics and policy claims sourced from federal-government and peer-reviewed agencies. Last verified May 2026.
This section covers state-level context for addiction treatment in Alaska: how the clinical continuum is structured, what federal resources are available, how insurance works in practice, and what evidence-based approaches apply to different substances and populations. The goal is to equip you to navigate Alaska treatment options effectively, whether you're researching for yourself or a family member.
Long-term recovery support for Alaska residents extends well beyond formal treatment. Mutual-support communities (AA, NA, SMART Recovery, Refuge Recovery, LifeRing, Recovery Dharma) offer structured peer support — research shows participation is associated with improved long-term outcomes when engagement is sustained. Recovery coaches, increasingly reimbursable by Medicaid in some Alaska regions, provide individualized recovery support outside the clinical framework. Recovery community organizations offer drop-in centers, social activities, advocacy, and peer support specialist training pathways.
Resources from federal agencies available to Alaska residents include: SAMHSA's National Helpline at 1-800-662-HELP (free, confidential, 24/7 in English and Spanish); the SAMHSA treatment-facility locator; CDC overdose-prevention guidance; NIDA (National Institute on Drug Abuse) patient-education materials; VA addiction-treatment programs for veterans; and the FDA's database of approved medications for opioid and alcohol use disorders. All are available without charge.
Medication-assisted treatment (MAT) is the evidence-based standard for opioid use disorder in Alaska. Three medications carry FDA approval: methadone (full opioid agonist, dispensed only at federally certified opioid treatment programs); buprenorphine (partial agonist, prescribed in office-based settings by waivered providers); and naltrexone (opioid antagonist, available as monthly injection). Multiple RCTs and meta-analyses show MAT reduces overdose death by approximately 50% versus abstinence-based approaches. NIDA, SAMHSA, ASAM, and the AMA all endorse MAT as first-line.
Withdrawal from alcohol or benzodiazepines can be medically dangerous and should not be attempted at home for Alaska residents with daily or heavy use. Signs of severe withdrawal requiring emergency care: seizures, hallucinations, severe tremor, disorientation, fever, autonomic instability (rapid heart rate, high blood pressure). Delirium tremens (DTs) carries a mortality rate around 5% without treatment and occurs in 3-5% of patients withdrawing from heavy alcohol use. Medical detox is the standard of care for these presentations.
Alaska treatment providers operate within the ASAM Criteria framework, which standardized placement decisions across the field. Withdrawal severity is the first screening factor — patients showing or at risk for moderate-to-severe alcohol or benzodiazepine withdrawal typically require medically managed detox before transitioning to lower-intensity care. Opioid use patients face a different decision tree: detox is rarely effective alone for opioid use disorder, and most evidence-based pathways involve medication-assisted treatment (MAT) initiated during stabilization.
Most Alaska residents pay for addiction treatment through one of four channels: commercial insurance (employer-sponsored or marketplace), Medicaid, Medicare, or self-pay. Commercial plans typically require pre-authorization for residential treatment, with medical necessity demonstrated through ASAM criteria documentation. Medicaid coverage varies by Alaska expansion status; the Medicaid agency in Alaska maintains a list of in-network treatment providers. Medicare Part A covers inpatient residential when medically necessary; Part B covers outpatient. Self-pay arrangements are negotiable.